These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 2118895)

  • 1. Characteristics of granulocyte-macrophage colony formation in chronic myelomonocytic leukemia: a comparative study with other myelodysplastic and myeloproliferative disorders.
    Yuo A; Miyazono K; Urabe A; Takaku F
    Jpn J Cancer Res; 1990 Aug; 81(8):820-6. PubMed ID: 2118895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High spontaneous colony growth in chronic myelomonocytic leukemia correlates with increased disease activity and is a novel prognostic factor for predicting short survival.
    Sagaster V; Ohler L; Berer A; Kabrna E; Ofner P; Lechner K; Geissler K
    Ann Hematol; 2004 Jan; 83(1):9-13. PubMed ID: 13680175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.
    Frankel AE; Lilly M; Kreitman R; Hogge D; Beran M; Freedman MH; Emanuel PD; McLain C; Hall P; Tagge E; Berger M; Eaves C
    Blood; 1998 Dec; 92(11):4279-86. PubMed ID: 9834234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
    Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z
    Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
    Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
    Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
    Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells.
    Geissler K; Ohler L; Födinger M; Virgolini I; Leimer M; Kabrna E; Kollars M; Skoupy S; Bohle B; Rogy M; Lechner K
    J Exp Med; 1996 Oct; 184(4):1377-84. PubMed ID: 8879210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic myelomonocytic leukemia requires granulocyte-macrophage colony-stimulating factor for growth in vitro and in vivo.
    Ramshaw HS; Bardy PG; Lee MA; Lopez AF
    Exp Hematol; 2002 Oct; 30(10):1124-31. PubMed ID: 12384142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
    Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
    Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.
    Invernizzi R; Travaglino E; Benatti C; Malcovati L; Della Porta M; Cazzola M; Ascari E
    Eur J Haematol; 2006 Jun; 76(6):494-501. PubMed ID: 16529600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].
    Germing U; Strupp C; Meckenstock G; Giagounidis A; Minning H; Aul C
    Med Klin (Munich); 1999 Sep; 94(9):467-72. PubMed ID: 10544608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes.
    Geissler K; Hinterberger W; Jäger U; Bettelheim P; Neumann E; Haas O; Ambros P; Chott A; Radaszkiewicz T; Lechner K
    Blut; 1988 Jul; 57(1):45-9. PubMed ID: 3390617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Carlo-Stella C; Cazzola M; Bergamaschi G; Bernasconi P; Dezza L; Invernizzi R; Pedrazzoli P
    Leukemia; 1989 May; 3(5):363-6. PubMed ID: 2654496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
    Shih LY; Chiu WF; Lee CT
    Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Problems in the classification of CMML--dysplastic versus proliferative type.
    Germing U; Gattermann N; Minning H; Heyll A; Aul C
    Leuk Res; 1998 Oct; 22(10):871-8. PubMed ID: 9766745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous colony forming ability in vitro of the abnormal clone-derived granulocyte-macrophage precursors in myelodysplastic syndromes.
    Okuda T; Yokota S; Maekawa T; Sonoda Y; Misawa S; Takino T; Abe T
    Leuk Res; 1988; 12(8):687-92. PubMed ID: 3184986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous oncogenic Nras mutation promotes aberrant GM-CSF signaling in granulocytic/monocytic precursors in a murine model of chronic myelomonocytic leukemia.
    Wang J; Liu Y; Li Z; Du J; Ryu MJ; Taylor PR; Fleming MD; Young KH; Pitot H; Zhang J
    Blood; 2010 Dec; 116(26):5991-6002. PubMed ID: 20921338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
    Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
    Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myelomonocytic leukemia: lost in classification?
    Bowen DT
    Hematol Oncol; 2005 Mar; 23(1):26-33. PubMed ID: 16149105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.